{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T02:23:57Z","timestamp":1785723837996,"version":"3.56.0"},"reference-count":34,"publisher":"Walter de Gruyter GmbH","issue":"6","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_cclm-2024-1455_abs_001\">\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Recently, four publications have applied Sigma metrics to infectious disease serology testing. Three studies applied Sigma metrics to assays in a blood bank setting, whereas one used anti-toxoplasma testing in a diagnostic laboratory. One of the four studies applied the approach to microtitre plate enzyme immunoassays, whereas the other three were on fully automated chemiluminescent assay. The approaches used by each study differed in the approach used to calculate imprecision, measured as a percentage coefficient of variation, and bias. All four studies used the difference between the mean of the quality control result and the assay cut-off to describe the total allowable error.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_cclm-2024-1455_abs_002\">\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This paper compares and critically reviews the methods used to calculate the Sigma value for each assay in the four studies and provides an evidence-based assessment of these approaches using real-world quality control data obtained from the National Serology Reference Laboratory, Australia (NRL) QConnect\u2122 quality control program.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_cclm-2024-1455_abs_003\">\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The assessment found that there was a lack of standardisation in the application of Sigma metrics for infectious disease testing, including examples of inappropriate assumptions being used. Westgard Sigma Rules suggest that assays found to have a Sigma value of six or greater can be monitored using two quality control measures and applying a single mean \u00b1 three standard deviation rule.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_cclm-2024-1455_abs_004\">\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Although this approach will significantly reduce the number of false rejections generated by using the full range of Westgard rules, we provide evidence that even this approach can potentially cause true errors to be missed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/cclm-2024-1455","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T11:40:41Z","timestamp":1739878841000},"page":"1228-1236","source":"Crossref","is-referenced-by-count":3,"title":["Evidence-based assessment of the application of Six Sigma to infectious disease serology quality control"],"prefix":"10.1515","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3425-9419","authenticated-orcid":false,"given":"Wayne","family":"Dimech","sequence":"first","affiliation":[{"name":"National Serology Reference Laboratory , Fitzroy , VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0972-0066","authenticated-orcid":false,"given":"Giuseppe","family":"Vincini","sequence":"additional","affiliation":[{"name":"National Serology Reference Laboratory , Fitzroy , VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"2025042506015781274_j_cclm-2024-1455_ref_001","doi-asserted-by":"crossref","unstructured":"Badrick, T, Theodorsson, E. Six sigma - is it time to re-evaluate its value in laboratory medicine? Clin Chem Lab Med 2024;62:2398\u2013400. https:\/\/doi.org\/10.1515\/cclm-2024-0377.","DOI":"10.1515\/cclm-2024-0377"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_002","doi-asserted-by":"crossref","unstructured":"Westgard, S, Bayat, H, Westgard, JO. Special issue on six sigma metrics - experiences and recommendations. Biochem Med (Zagreb) 2018;28:020301. https:\/\/doi.org\/10.11613\/bm.2018.020301.","DOI":"10.11613\/BM.2018.020301"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_003","doi-asserted-by":"crossref","unstructured":"Westgard, S, Bayat, H, Westgard, JO. Analytical Sigma metrics: a review of six sigma implementation tools for medical laboratories. Biochem Med (Zagreb) 2018;28:020502. https:\/\/doi.org\/10.11613\/bm.2018.020502.","DOI":"10.11613\/BM.2018.020502"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_004","doi-asserted-by":"crossref","unstructured":"Nevalainen, D, Berte, L, Kraft, C, Leigh, E, Picaso, L, Morgan, T. Evaluating laboratory performance on quality indicators with the six sigma scale. Arch Pathol Lab Med 2000;124:516\u20139. https:\/\/doi.org\/10.5858\/2000-124-0516-elpoqi.","DOI":"10.5858\/2000-124-0516-ELPOQI"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_005","doi-asserted-by":"crossref","unstructured":"Thakur, V, Akerele, OA, Randell, E. Lean and six sigma as continuous quality improvement frameworks in the clinical diagnostic laboratory. Crit Rev Clin Lab Sci 2023;60:63\u201381. https:\/\/doi.org\/10.1080\/10408363.2022.2106544.","DOI":"10.1080\/10408363.2022.2106544"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_006","doi-asserted-by":"crossref","unstructured":"Raisinghani, MS, Ette, H, Pierce, R, Cannon, G, Daripaly, P. Six sigma: concepts,tools, and applications. Ind Manag Data Syst 2005;105:491\u2013505. https:\/\/doi.org\/10.1108\/02635570510592389.","DOI":"10.1108\/02635570510592389"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_007","doi-asserted-by":"crossref","unstructured":"Ninerola, A, Sanchez-Rebull, MV, Hernandez-Lara, AB. Quality improvement in healthcare: six sigma systematic review. Health Policy 2020;124:438\u201345. https:\/\/doi.org\/10.1016\/j.healthpol.2020.01.002.","DOI":"10.1016\/j.healthpol.2020.01.002"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_008","doi-asserted-by":"crossref","unstructured":"Wauthier, L, Di Chiaro, L, Favresse, J. Sigma metrics in laboratory medicine: a call for harmonization. Clin Chim Acta 2022;532:13\u201320. https:\/\/doi.org\/10.1016\/j.cca.2022.05.012.","DOI":"10.1016\/j.cca.2022.05.012"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_009","doi-asserted-by":"crossref","unstructured":"Bhatnagar, S, Westgard, S, Dung, NTT, Que, TN, Khanh, BQ, Thanh, NH. Applying sigma metrics to assess quality control processes in the transfusion transmissible infection screening laboratory of a blood center. PLoS One 2024;19:e0312422. https:\/\/doi.org\/10.1371\/journal.pone.0312422.","DOI":"10.1371\/journal.pone.0312422"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_010","doi-asserted-by":"crossref","unstructured":"Khelil, MM. Six Sigma driven QC in antibody testing for infectious diseases. Clin Chem Lab Med 2024;62:e40\u20133. https:\/\/doi.org\/10.1515\/cclm-2023-0552.","DOI":"10.1515\/cclm-2023-0552"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_011","doi-asserted-by":"crossref","unstructured":"Scheurich, G, Bhatnagar, S, Westgard, S. Sigma metrics analysis of serology screening assays to enhance quality and efficiency in New Zealand blood services. Diagn Microbiol Infect Dis 2024;110:116451. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116451.","DOI":"10.1016\/j.diagmicrobio.2024.116451"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_012","doi-asserted-by":"crossref","unstructured":"Moya-Salazar, J, D\u00edaz- Rosado, RF. Quality analytical planning in blood bank serological screening qualitative assays. Int Clin Pathol J 2019;7:22\u20136. https:\/\/doi.org\/10.15406\/icpjl.2019.07.00194.","DOI":"10.15406\/icpjl.2019.07.00194"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_013","unstructured":"Pereira, P. Quality control of qualitative tests for medical laboratories. Portugal: Grafisol; 2019."},{"key":"2025042506015781274_j_cclm-2024-1455_ref_014","doi-asserted-by":"crossref","unstructured":"Green, GA, Carey, RN, Westgard, JO, Carten, T, Shablesky, L, Achord, D, et al.. Quality control for qualitative assays: quantitative QC procedure designed to assure analytical quality required for an ELISA of hepatitis B surface antigen. Clin Chem 1997;43:1618\u201321. https:\/\/doi.org\/10.1093\/clinchem\/43.9.1618.","DOI":"10.1093\/clinchem\/43.9.1618"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_015","doi-asserted-by":"crossref","unstructured":"Westgard, JO, Westgard, SA. Quality control review: implementing a scientifically based quality control system. Ann Clin Biochem 2016;53:32\u201350. https:\/\/doi.org\/10.1177\/0004563215597248.","DOI":"10.1177\/0004563215597248"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_016","doi-asserted-by":"crossref","unstructured":"Dimech, W, Karakaltsas, M, Vincini, GA. Comparison of four methods of establishing control limits for monitoring quality controls in infectious disease serology testing. Clin Chem Lab Med 2018;56:1970\u20138. https:\/\/doi.org\/10.1515\/cclm-2018-0351.","DOI":"10.1515\/cclm-2018-0351"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_017","doi-asserted-by":"crossref","unstructured":"Dimech, WJ, Vincini, GA, Plebani, M, Lippi, G, Nichols, JH, Sonntag, O. Response to Tony Badrick regarding \u201cLetter to the Editor regarding the article by Wayne J.\u00a0Dimech et\u00a0al. Time to address quality control processes applied to antibody testing for infectious diseases. Clin Chem Lab Med 2023;61:205\u201312 by\u201d. Clin Chem Lab Med 2023;61:e137\u2013e139, https:\/\/doi.org\/10.1515\/cclm-2022-0986.","DOI":"10.1515\/cclm-2023-0178"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_018","unstructured":"CLSI. Statistical quality control for quantitative measurement procedures: principles and definitions in CLSI Guideline. Wayne, PA: Clinical and Laboratory Standards Institute; 2016."},{"key":"2025042506015781274_j_cclm-2024-1455_ref_019","doi-asserted-by":"crossref","unstructured":"Dimech, WJ, Vincini, GA, Cabuang, LM, Wieringa, M. Does a change in quality control results influence the sensitivity of an anti-HCV test? Clin Chem Lab Med 2020;58:1372\u201380. https:\/\/doi.org\/10.1515\/cclm-2020-0031.","DOI":"10.1515\/cclm-2020-0031"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_020","doi-asserted-by":"crossref","unstructured":"Dimech, W, Vincini, G, Karakaltsas, M. Determination of quality control limits for serological infectious disease testing using historical data. Clin Chem Lab Med 2015;53:329\u201336. https:\/\/doi.org\/10.1515\/cclm-2014-0546.","DOI":"10.1515\/cclm-2014-0546"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_021","doi-asserted-by":"crossref","unstructured":"Levine, JB. How the Westgard QC rules got their name: a personal recollection. Clin Chem 2018;64:874\u20136. https:\/\/doi.org\/10.1373\/clinchem.2018.288696.","DOI":"10.1373\/clinchem.2018.288696"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_022","doi-asserted-by":"crossref","unstructured":"Pereira, P. A non-parametric framework for evaluating total analytical error in in\u00a0vitro diagnostic medical devices in transfusion medicine. Transfus Apher Sci 2024;63:104026. https:\/\/doi.org\/10.1016\/j.transci.2024.104026.","DOI":"10.1016\/j.transci.2024.104026"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_023","doi-asserted-by":"crossref","unstructured":"Bayat, H, Westgard, SA, Westgard, JO. The value of Sigma-metrics in laboratory medicine. Clin Chem Lab Med 2024;62:2401\u20134. https:\/\/doi.org\/10.1515\/cclm-2024-0609.","DOI":"10.1515\/cclm-2024-0609"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_024","doi-asserted-by":"crossref","unstructured":"Liu, Q, Chen, X, Han, J, Chen, Y, Wang, M, Zhao, J, et al.. Application of a six sigma model to the evaluation of the analytical performance of serum enzyme assays and the design of a quality control strategy for these assays: a multicentre study. Clin Biochem 2021;91:52\u20138. https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.02.004.","DOI":"10.1016\/j.clinbiochem.2021.02.004"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_025","doi-asserted-by":"crossref","unstructured":"Khelil, MM. Letter to the Editor on article Scheurich G, Bhatnagar S, Westgard S. Sigma metrics analysis of serology screening assays to enhance quality and efficiency in New Zealand blood services. Diagnostic Microbiology & Infectious Disease 110 (2024). Diagn Microbiol Infect Dis 2025;111:116608.","DOI":"10.1016\/j.diagmicrobio.2024.116608"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_026","doi-asserted-by":"crossref","unstructured":"Dimech, W, Vincini, G, Karakaltas, M. Counterpoint to the Letter to the Editor by Badrick and Parvin in regard to Comparison of four methods of establishing control limits for monitoring quality controls in infectious disease serology testing. Clin Chem Lab Med 2019;57:e73\u20134. https:\/\/doi.org\/10.1515\/cclm-2018-1321.","DOI":"10.1515\/cclm-2018-1321"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_027","doi-asserted-by":"crossref","unstructured":"Dimech, WJ, Vincini, GA, Plebani, M, Lippi, G, Nichols, JH, Sonntag, O. Time to address quality control processes applied to antibody testing for infectious diseases. Clin Chem Lab Med 2023;61:205\u201312. https:\/\/doi.org\/10.1515\/cclm-2022-0986.","DOI":"10.1515\/cclm-2022-0986"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_028","doi-asserted-by":"crossref","unstructured":"Plebani, M, Gillery, P, Greaves, RF, Lackner, KJ, Lippi, G, Melichar, B, et al.. Rethinking internal quality control: the time is now. Clin Chem Lab Med 2022;60:1316\u201317. https:\/\/doi.org\/10.1515\/cclm-2022-0587.","DOI":"10.1515\/cclm-2022-0587"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_029","doi-asserted-by":"crossref","unstructured":"Plebani, M, Zaninotto, M. Lot-to-lot variation: no longer a neglected issue. J Clin Chem Lab Med 2022;60:645\u20136. https:\/\/doi.org\/10.1515\/cclm-2022-0128.","DOI":"10.1515\/cclm-2022-0128"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_030","unstructured":"Ellison, SLR, Williams, A. Quantifying uncertainty in analytical measurement: EURACHEM\/CITAC guide CG 4; 2012."},{"key":"2025042506015781274_j_cclm-2024-1455_ref_031","doi-asserted-by":"crossref","unstructured":"Dimech, W, Francis, B, Kox, J, Roberts, G, Serology Uncertainty of Measurement Working Party. Calculating uncertainty of measurement for serology assays by use of precision and bias. Clin Chem 2006;52:526\u20139. https:\/\/doi.org\/10.1373\/clinchem.2005.056689.","DOI":"10.1373\/clinchem.2005.056689"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_032","doi-asserted-by":"crossref","unstructured":"Dimech, W, Vincini, G, McEwan, B. External quality control processes for infectious disease testing. ASM Affairs 2024;45:41\u20133. https:\/\/doi.org\/10.1071\/ma24013.","DOI":"10.1071\/MA24013"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_033","doi-asserted-by":"crossref","unstructured":"Dimech, W. The standardization and control of serology and nucleic acid testing for infectious diseases. Clin Microbiol Rev 2021;34. https:\/\/doi.org\/10.1128\/cmr.00035-21.","DOI":"10.1128\/CMR.00035-21"},{"key":"2025042506015781274_j_cclm-2024-1455_ref_034","doi-asserted-by":"crossref","unstructured":"Plebani, M, Lippi, G. Standardization and harmonization in laboratory medicine: not only for clinical chemistry measurands. Clin Chem Lab Med 2023;61:185\u20137. https:\/\/doi.org\/10.1515\/cclm-2022-1122.","DOI":"10.1515\/cclm-2022-1122"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2024-1455\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2024-1455\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T06:03:58Z","timestamp":1745561038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2024-1455\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,1,21]]},"published-print":{"date-parts":[[2025,5,26]]}},"alternative-id":["10.1515\/cclm-2024-1455"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2024-1455","relation":{},"ISSN":["1434-6621","1437-4331"],"issn-type":[{"value":"1434-6621","type":"print"},{"value":"1437-4331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]}}}